4.7 Article

Mitophagy enhancers against phosphorylated Tau-induced mitochondrial and synaptic toxicities in Alzheimer disease

Related references

Note: Only part of the references are listed.
Review Cell Biology

Synaptic basis of Alzheimer's disease: Focus on synaptic amyloid beta, P-tau and mitochondria

Albin John et al.

Summary: Alzheimer's disease is a progressive disease associated with synaptic dysfunction, with researchers striving to find more information on disease progression and pathogenesis. Synaptic pathology and mitochondrial oxidative damage are early events in the progression of AD, with synaptic loss and damage being key correlates of cognitive deficits in patients. As the disease advances, significant changes occur at the synapse, shedding light on the disease progression and serving as potential markers and therapeutic targets.

AGEING RESEARCH REVIEWS (2021)

Review Neurosciences

Defective Autophagy and Mitophagy in Aging and Alzheimer's Disease

Michael Tran et al.

Summary: Aging is a time-dependent process characterized by declining physiological function due to metabolic and molecular changes. Factors such as epigenetic changes, telomere length, oxidative damage, and mitochondrial dysfunction play major roles in assessing biological age. Dysfunctions in autophagy and mitophagy are implicated in the pathogenesis of age-related diseases like Alzheimer's disease.

FRONTIERS IN NEUROSCIENCE (2021)

Article Biochemistry & Molecular Biology

Protective effects of antidepressant citalopram against abnormal APP processing and amyloid beta-induced mitochondrial dynamics, biogenesis, mitophagy and synaptic toxicities in Alzheimer's disease

Arubala P. Reddy et al.

Summary: The study found that citalopram has a protective effect against mutant APP, Aβ, and mitochondrial toxicities, suggesting a potential neuroprotective role in patients with depression, anxiety, and AD.

HUMAN MOLECULAR GENETICS (2021)

Article Biochemistry & Molecular Biology

Selective serotonin reuptake inhibitor citalopram ameliorates cognitive decline and protects against amyloid beta-induced mitochondrial dynamics, biogenesis, autophagy, mitophagy and synaptic toxicities in a mouse model of Alzheimer's disease

Arubala P. Reddy et al.

Summary: The study investigates the protective role of citalopram against cognitive decline, impaired mitochondrial dynamics, and synaptic dysfunction in an Alzheimer's disease mouse model. Citalopram treatment improved cognitive behavior, reduced Aβ levels, and decreased mitochondrial and synaptic toxicities in the treated mice compared to the untreated mice. The findings suggest that citalopram may have a strong protective effect against injuries induced by mutant APP and Aβ in depression, anxiety, and AD patients.

HUMAN MOLECULAR GENETICS (2021)

Article Biochemistry & Molecular Biology

Defective mitophagy and synaptic degeneration in Alzheimer's disease: Focus on aging, mitochondria and synapse

Hallie Morton et al.

Summary: Alzheimer's disease is a progressive neurodegenerative disease characterized by multiple cellular changes, mitochondrial dysfunction, and brain damage, ultimately leading to cognitive impairment.

FREE RADICAL BIOLOGY AND MEDICINE (2021)

Article Neurosciences

Mitochondrial Abnormalities and Synaptic Damage in Huntington's Disease: a Focus on Defective Mitophagy and Mitochondria-Targeted Therapeutics

Neha Sawant et al.

Summary: Huntington's disease is a fatal genetic disease involving multiple cellular changes, with therapeutic strategies focusing on reducing abnormal protein interactions and enhancing synaptic mitophagy.

MOLECULAR NEUROBIOLOGY (2021)

Review Neurosciences

Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances

Wenzhang Wang et al.

MOLECULAR NEURODEGENERATION (2020)

Review Cell Biology

Defective mitophagy in Alzheimer's disease

Jangampalli Adi Pradeepkiran et al.

AGEING RESEARCH REVIEWS (2020)

Review Biochemistry & Molecular Biology

The Alzheimer's disease mitochondrial cascade hypothesis: Progress and perspectives

Russell H. Swerdlow et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)

Article Pharmacology & Pharmacy

Mitochondrial Biogenesis in Health and Disease. Molecular and Therapeutic Approaches

Fabian Sanchis-Gomar et al.

CURRENT PHARMACEUTICAL DESIGN (2014)

Editorial Material Pharmacology & Pharmacy

Mitochondrial Biogenesis: Pharmacological Approaches

Teresa Valero

CURRENT PHARMACEUTICAL DESIGN (2014)

Review Neurosciences

Abnormal Mitochondrial Dynamics in the Pathogenesis of Alzheimer's Disease

Xiongwei Zhu et al.

JOURNAL OF ALZHEIMERS DISEASE (2013)

Review Biochemistry & Molecular Biology

Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: Implications to mitochondria-targeted antioxidant therapeutics

P. Hemachandra Reddy et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)

Review Biochemistry & Molecular Biology

Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer's disease: Implications for early intervention and therapeutics

Peizhong Mao et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)

Article Clinical Neurology

Nutritional Approaches to Modulate Oxidative Stress in Alzheimers Disease

C. B. Pocernich et al.

Current Alzheimer Research (2011)

Review Neurosciences

Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease

P. Hemachandra Reddy

EXPERIMENTAL NEUROLOGY (2009)

Article Neurosciences

Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease

Xinglong Wang et al.

JOURNAL OF NEUROSCIENCE (2009)

Article Multidisciplinary Sciences

Amyloid-β overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins

Xinglong Wang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Multidisciplinary Sciences

Mitochondrial Oxidative Stress Causes Hyperphosphorylation of Tau

Simon Melov et al.

PLOS ONE (2007)

Review Biochemistry & Molecular Biology

Emerging functions of mammalian mitochondrial fusion and fission

HC Chen et al.

HUMAN MOLECULAR GENETICS (2005)

Review Biochemistry & Molecular Biology

Tau alteration and neuronal degeneration in tauopathies: mechanisms and models

R Brandt et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)

Review Biochemistry & Molecular Biology

Tau pathology in Alzheimer disease and other tauopathies

K Iqbal et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)

Review Physiology

Role of tau protein in both physiological and pathological conditions

J Avila et al.

PHYSIOLOGICAL REVIEWS (2004)

Review Multidisciplinary Sciences

Pathways towards and away from Alzheimer's disease

MP Mattson

NATURE (2004)

Article Neurosciences

Mitochondrial abnormalities in Alzheimer's disease

K Hirai et al.

JOURNAL OF NEUROSCIENCE (2001)

Review Physiology

Alzheimer's disease: Genes, proteins, and therapy

DJ Selkoe

PHYSIOLOGICAL REVIEWS (2001)